Riding the Waves to Success in Assisted Reproductive Technology

Kaneka Corporation is pleased to exhibit at the Fertility Society of Australia and New Zealand (FSANZ) Annual Conference 2023, four-day event held at the Gold Coast Convention & Exhibition Centre, Queensland from 3–6 June 2023.

The FSANZ committee curated an engaging and educational scientific program, including interactive panel sessions hosted by keynote speakers from across the globe, covering all areas of assisted reproductive technology (ART).

This highly anticipated conference, centred around the theme “Riding the wave to success”, united leading experts, researchers and practitioners in the field of reproductive medicine. Kaneka Corporation, a global leader in healthcare solutions, took part in the conversations and education opportunities associated with this theme and its continued commitment to innovation, advancement and success in the realm of fertility treatment and reproductive healthcare.

Backed by research, development and testing, Kaneka Corporation is the only raw material supplier of the Ubiquinol ingredient, available today, which is utilised in hundreds of consumer products around the world to support overall health, including male fertility.[i]

Through active engagement, knowledge sharing and showcasing its innovative contributions, Kaneka Corporation aims to further strengthen its commitment to the integrative health industry, supporting patient outcomes and learning more about the benefits of ubiquinol and the role it plays in supporting male fertility.

Reference:
[i] https://www.ubiquinol.net.au/health-benefits/fertility/